The content below is not actively maintained and may be out of date. We last updated the content below in 2009.
More information:
APOC focuses on mass drug administration to control onchocerciasis (river blindness), which can result in significant reductions in the skin disease and vision problems associated with river blindness. Its primary aim is "The establishment of sustainable national onchocerciasis control programmes in all African countries where such programmes are needed."1
APOC's focus is on mass drug administration of onchocerciasis programs.
APOC lists its primary activities as:
We do not have all the necessary information to determine how APOC's funds break down across these activities. It does provide a chart of its 2007 expenses, but they are broken down by different (and not entirely clear) categories. The chart is reproduced below.9
This chart implies that the majority of APOC expenses directly fund local projects. However, we do not know specifically how local projects utilize these funds. We also do not know how to match the expenses provided by APOC here to their activities listed above. We discuss this further below.
APOC's primary aim is "Establishing sustainable community-directed treatment with ivermectin in all African countries, where such programmes are needed."10 We believe that this program - when implemented well - is likely effective against onchocerciasis, though evidence of an effect on debilitating outcomes is not conclusive. For more, see our full report on this program.
However, we are not convinced that APOC is effectively translating funding into implementation of this program. Most of its funding is provided to developing-world governments, raising a question of whether they spend it as intended. APOC does perform some monitoring of its grant recipients, but we are concerned that it does not sufficiently hold them accountable.
APOC mentions (a) monitoring reports focused on whether projects are implemented according to requirements and (b) evaluations of financial documents submitted to APOC by funded projects. Based on the information below, we believe that the monitoring reports identify significant, potential problems with project implementation and financial reporting, but we don't see evidence that these findings lead to significant action by APOC towards non-performing projects. We are therefore concerned about APOC's willingness and ability to hold funding recipients accountable.
Project implementation
APOC reports that "All CDTI projects go through M&E [monitoring and evaluation]. To date, a total of 64 projects had undergone independent participatory monitoring.... Independent participatory monitoring is conducted by a team, consisting of 2 external and 4 monitors and takes place in the second year of a CDTI project."11 It appears that only a relatively small proportion of APOC's total projects have undergone evaluation: its statements about financial returns imply at least 1200 completed or ongoing projects,12 a number that dwarfs the 64 that have been monitored/evaluated to date.
We have relatively little information on the specifics of monitoring and evaluation. The 2007 Progress report states that "two projects in Tanzania (Tunduru and Morogoro) were monitored during the period under review,"13 and gives the following findings:14
It is not clear to us specifically how these conclusions were reached, or whether there were any consequences for the insufficient reporting of supervisory activities.
Reporting requirements
APOC also reviews individual country reports, assessing whether they meet reporting requirements. These reports do not seem to assess whether projects have been implemented appropriately.15 In 2007, APOC rejected a number of reports including a project in the Congo,16 multiple projects in Malawi,17 and multiple projects in Uganda.18 However, it is not clear to us whether rejection of these reports was accompanied by any consequences related to funding.
Financials
APOC receives and reviews financial returns from projects they support. However, in 2007-08, APOC only received 60% of the returns that were due.19 In addition, a significant number of projects were more than four months late in submitting financial returns, a delay APOC considers particularly egregious.20 In response, APOC stated that "all concerned partners should find ways of improving the situation."21
APOC only funds a portion of project expenses - the remainder are contributed by governments and partner NGOs - so the APOC expense figures we have do not provide a reasonable estimate of total program costs. Independent estimates imply that the type of program APOC focuses on is highly cost-effective: $7-$40 per disability-adjusted life-year (DALY) averted , or $100 to avert a total of 10-50 years of serious debilitation (blindness, low vision, or irritating skin disease). Details on cost-effectiveness here; more on the DALY metric here.
Because of our concerns about APOC's implementation (see above), we don't have confidence that it can be expected to reliably achieve this level of cost-effectiveness, and have little with which to construct a more realistic estimate.
We have not seen any expansion plan, "funding gap" analysis, or list of strong but underfunded proposals from APOC. We also do not have basic financial data for the organization. As such, we have little sense of whether it can productively use more funding.
In 2007, APOC had a budget of $13.5 million.22 We do not have financial data for previous years.
Revenue and expense growth (about this metric): We do not have the information necessary to make this assessment.
Assets-to-expenses ratio (about this metric): We do not have the information necessary to make this assessment.
Expenses by program area (about this metric): The chart above provides this information. 55% of APOC's expenses are used to fund countries' MDA projects.
Expenses by IRS-reported category (about this metric): We do not have the information necessary to make this assessment.
"The establishment of sustainable national onchocerciasis control programmes in all African countries where such programmes are needed remains the key preoccupation of APOC. The mapping of the endemicity of onchocerciasis has now been completed in 12 of the 19 countries and efforts are being made in collaboration with Lancaster University in UK for a better delineation of the areas co-endemic for onchocerciaisis and loiasis to guide safe ivermectin (Mectizan®) mass distribution in all countries." APOC, "Progress Report (2007)," Pg vi.
"Establishing sustainable community-directed treatment with ivermectin in all African countries, where such programmes are needed, is the key preoccupation of APOC. There are three main aspects to attaining this objective: establishing a sustainable system for disease mapping, maintaining high coverage of ivermectin distribution and managing severe adverse events; creating adequate capacity to sustain control programmes; and ensuring effective programme management and partnerships to enhance the sustainability of control programmes." APOC, "Progress Report (2007)," Pg 2.
"One hundred and seven CDTI projects were funded. This includes five new CDTI projects launched in 2007 in DRC (3) and Angola (2), as well as six NOTF Secretariat- support projects. Two projects in North Sudan (Northern Sector CDTI project and NOTF Secretariat) were not funded because the project did not present a plan of action and budget. All projects that complied with WHO/APOC financial rules and procedures received funds from the Trust Fund for their activities. 55% of the approved budget was allocated to national projects." APOC, "Progress Report (2007)," Pg 21.
APOC also funds vector elimination activities, though these appear to be a very small part of what it does. "APOC's mandate in this area is limited to four foci: Itwara and Mpamba-Nkusi (Uganda), Bioko Island (Equatorial Guinea) and Tukuyu focus (Tanzania), and restricted to ground larviciding except in Bioko Island where combined ground and aerial spraying was undertaken." APOC, "Progress Report (2007)," Pg 20.
"183. APOC conducts three activities globally in all APOC countries. The first activity is the independent participatory monitoring, which is conducted in year two of the project with two objectives. Firstly, to determine whether the process of Community-Directed approach is being put in place in the communities as a way to empower the communities; and secondly to look at the treatment coverage." WHO, "African Programme for Onchocerciasis Control," Pg 46.
"184. The second activity is an evaluation, which is conducted after three years of project implementation. The main objective of the evaluation is to find out if the project is moving towards sustainability. Following the evaluation, the evaluation team remains in the country to assist the project develop sustainability plans, which clearly indicate the financial contribution of the Ministry of Health and partners. At this stage of the process, APOC financial support is decreased, and support is limited to logistics (vehicles and office equipment). 185. The third activity is the monitoring of the implementation of the sustainability plan. This activity is funded by APOC and conducted by a team of six people, two of whom are external and appointed by APOC, one NGDO partner and three local people selected by the country. From that year on, the country becomes responsible for carrying out independent monitoring, and it could select one external person to join the local team for the activity." WHO, "African Programme for Onchocerciasis Control," Pg 46.
Examples:
The 2007 Progress Report provides data on:
The 2008 Technical Consultative Committee Report provides APOC's decision on whether the country has complied with its requirements, along with brief blurbs on each country's program, and suggestions for improvements to the program (Pgs 14-46).
One example is the Macrofil program: "The WHO/TDR -APOC Macrofil programme has made remarkable advances in the search for a potential macrofilaricide for Onchocerciasis elimination/eradication." APOC, "Progress Report (2007)," Pg 19.
The APOC management undertook several missions to 14 APOC countries, in collaboration with the Technical Consultative Committee (TCC) members, the Non-Governmental Development Organizations (NGDOs) Coordination Group members, and other external experts during the period under review. These were for technical advice on collaboration with other programmes; advice on integration and co-implementation with malaria plus initiative; meetings with policy and decision-makers to improve CDTI through integrated approach; review of the onchocerciasis control situation; and clarification of the role and contribution of different partners. The missions reviewed and advised on administrative and financial operations of CDTI projects; re-launching CDTI activities in some countries, facilitated training workshops on APOC philosophy and the CDTI strategy for project managers; trained accountants in the WHO accounting system and collection of CDTI data." APOC, "Progress Report (2007)," Pg 22.
APOC, "Progress Report (2007)," Pg 22.
APOC, "Progress Report (2007)," Pg 2.
APOC, "Progress Report (2007)," Pgs 10-11.
"Out of the 1209 financial returns to be received for 2007-2008, 724 were received (equivalent to 60%) and 626 (86% of the received returns) were analysed by the AAF at the country level and APOC HQ." WHO, "African Programme for Onchocerciasis Control," Pg 13.
APOC, "Progress Report (2007)," Pgs 10-11.
APOC, "Progress Report (2007)," Pg 11.
WHO, "African Programme for Onchocerciasis Control," Pgs 14-46.
WHO, "African Programme for Onchocerciasis Control," Pg 31.
WHO, "African Programme for Onchocerciasis Control," Pgs 36-39.
WHO, "African Programme for Onchocerciasis Control," Pg 45.
"Out of the 1209 financial returns to be received for 2007-2008, 724 were received (equivalent to 60%) and 626 (86% of the received returns) were analysed by the AAF at the country level and APOC HQ. At the end of February 2008, 99 returns are to be analysed by APOC Headquarters." WHO, "African Programme for Onchocerciasis Control," Pg 13.
"As of 29 February 2008, 51 projects had red cards meaning they are more than four months late in submitting financial returns. The release of funds to these projects has been suspended until they submit the 403 returns concerned." WHO, "African Programme for Onchocerciasis Control," Pg 13.
WHO, "African Programme for Onchocerciasis Control," Pg 13.
APOC, "Progress Report (2007)," Pg 21.